BridgeMD
Compares treatment options for Osteo Arthritis Knee
Official title Total Versus Robotic Assisted Unicompartmental Knee Replacement
ClinicalTrials.gov ID: NCT05290818
What this study is testing
- What it's testing
- The purpose of this research is to compare the functional outcomes of patients with end stage medial compartment OA of the knee undergoing a conventional mTKA to those undergoing rUKA and to assess the associated cost economics of such technology.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 75
You may be able to join if
- Listed for elective primary TKA for end stage medial compartment osteoarthritis
- Intact anterior cruciate ligament
- Full thickness and good quality lateral cartilage
- Correctable intra-articular varus deformity and intact medial collateral ligament
- American Society of Anesthesiologists (ASA) grades 1 and 2
You likely can't join if
- Varus deformity of \> 20 degrees
- Fixed flexion of \>10 degrees
- Patient is unable to comply with the study protocol (incl. refusal for CT scan) or functional assessments
- Female participants who are pregnant, lactating or planning pregnancy during the course of the study
- Requires patella resurfacing or lateral compartment has significant OA
- Inability to understand the patient information for the study, provide written informed consent or answer study questionnaires for cognitive or...
See the full eligibility criteria
- Listed for elective primary TKA for end stage medial compartment osteoarthritis
- Intact anterior cruciate ligament
- Full thickness and good quality lateral cartilage
- Correctable intra-articular varus deformity and intact medial collateral ligament
- American Society of Anesthesiologists (ASA) grades 1 and 2
- Male or female, age 50 - 75 at the time of listing for surgery
- Suitable candidate for a cruciate retaining TKA (Triathlon prosthesis) and a UKA
- Varus deformity of \> 20 degrees
- Fixed flexion of \>10 degrees
- Patient is unable to comply with the study protocol (incl. refusal for CT scan) or functional assessments
- Female participants who are pregnant, lactating or planning pregnancy during the course of the study
- Requires patella resurfacing or lateral compartment has significant OA
- Inability to understand the patient information for the study, provide written informed consent or answer study questionnaires for cognitive or language reasons
- Inflammatory disorder e.g. rheumatoid arthritis
- Symptomatic foot, hip or spine pathology
- Prior surgery (other than arthroscopy) or septic arthritis of the knee
- Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study,
The study team makes the final eligibility decision.
Where it's taking place
- Edinburgh, Lothian, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edinburgh, Lothian, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.